Recombinant Human Growth Hormone [EPC]

Recombinant Human Growth Hormone [EPC] was reported 21996 times

These side effects are most commonly reported by patients taking drugs of the Recombinant Human Growth Hormone [EPC] class:

# Drug class Count
0 INJECTION SITE PAIN 1940
1 DEVICE BREAKAGE 1703
2 DEVICE LEAKAGE 1646
3 INCORRECT DOSE ADMINISTERED 1233
4 PRODUCT DOSE OMISSION ISSUE 1165
5 INCORRECT DOSE ADMINISTERED BY DEVICE 1155
6 HEADACHE 1084
7 DEVICE ISSUE 1000
8 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 925
9 DRUG DOSE OMISSION BY DEVICE 848
10 OFF LABEL USE 836
11 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 690
12 INJECTION SITE HAEMORRHAGE 659
13 INJECTION SITE BRUISING 637
14 DEVICE MECHANICAL ISSUE 602
15 FATIGUE 558
16 DRUG INEFFECTIVE 542
17 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 521
18 DEVICE MALFUNCTION 506
19 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 476
20 ARTHRALGIA 447
21 PRODUCT STORAGE ERROR 442
22 NEEDLE ISSUE 417
23 VOMITING 407
24 PAIN 399
25 MALAISE 397
26 DEVICE DIFFICULT TO USE 382
27 PYREXIA 380
28 DEATH 372
29 NAUSEA 358
30 DEVICE DEFECTIVE 318
31 PAIN IN EXTREMITY 312
32 DIZZINESS 287
33 PRODUCT USE IN UNAPPROVED INDICATION 276
34 WEIGHT INCREASED 275
35 DEVICE DELIVERY SYSTEM ISSUE 271
36 SEIZURE 271
37 THERAPY INTERRUPTED 259
38 PRODUCT AVAILABILITY ISSUE 258
39 ACCIDENTAL EXPOSURE TO PRODUCT 257
40 DEVICE USE ERROR 249
41 DEVICE USE ISSUE 237
42 FALL 225
43 DIARRHOEA 223
44 INJECTION SITE DISCHARGE 222
45 HOSPITALISATION 217
46 ANXIETY 216
47 ASTHENIA 215
48 CONDITION AGGRAVATED 211
49 INSOMNIA 204
50 BRAIN NEOPLASM 199
51 WEIGHT DECREASED 199
52 PNEUMONIA 197
53 SLEEP APNOEA SYNDROME 194
54 PRODUCT USE ISSUE 187
55 RASH 186
56 POOR QUALITY DEVICE USED 179
57 DYSPNOEA 176
58 GROWTH RETARDATION 173
59 ABDOMINAL PAIN UPPER 165
60 CONTUSION 165
61 COVID-19 165
62 NASOPHARYNGITIS 165
63 EXPIRED DEVICE USED 163
64 SOMNOLENCE 160
65 FEELING ABNORMAL 159
66 ABDOMINAL PAIN 158
67 EXPOSURE VIA SKIN CONTACT 158
68 PERIPHERAL SWELLING 157
69 DRUG ADMINISTERED IN WRONG DEVICE 153
70 HYPERSENSITIVITY 151
71 COUGH 150
72 THERAPY CESSATION 150
73 HYPERTENSION 148
74 DEVICE OCCLUSION 147
75 DECREASED APPETITE 146
76 LIQUID PRODUCT PHYSICAL ISSUE 143
77 BLOOD GLUCOSE INCREASED 141
78 SCOLIOSIS 139
79 INSULIN-LIKE GROWTH FACTOR INCREASED 138
80 DEPRESSION 135
81 HYPOGLYCAEMIA 134
82 ILLNESS 134
83 BACK PAIN 128
84 FEAR OF INJECTION 126
85 CONSTIPATION 124
86 MEMORY IMPAIRMENT 124
87 PRODUCT QUALITY ISSUE 123
88 INJECTION SITE EXTRAVASATION 122
89 UNDERDOSE 122
90 CRYING 120
91 DRUG ABUSE 120
92 INJECTION SITE ERYTHEMA 119
93 MULTIPLE USE OF SINGLE-USE PRODUCT 119
94 INFLUENZA 117
95 GAIT DISTURBANCE 114
96 DEVICE PHYSICAL PROPERTY ISSUE 113
97 SYNCOPE 113
98 WRONG DEVICE USED 113
99 DRUG DOSE OMISSION 110
100 MYALGIA 110
101 URTICARIA 110
102 INJECTION SITE MASS 108
103 PRODUCT PRESCRIBING ERROR 105
104 LOSS OF CONSCIOUSNESS 103
105 PRODUCT DOSE OMISSION 103
106 PRURITUS 103
107 CRANIOPHARYNGIOMA 101
108 CEREBROVASCULAR ACCIDENT 100
109 INJECTION SITE SWELLING 100
110 DRUG INTERACTION 99
111 OVERDOSE 99
112 TREMOR 98
113 MIGRAINE 97
114 PRODUCT USE COMPLAINT 97
115 INTENTIONAL PRODUCT MISUSE 96
116 VISUAL IMPAIRMENT 96
117 EPILEPSY 95
118 INFECTION 93
119 INJECTION SITE REACTION 89
120 HYPERHIDROSIS 88
121 INJECTION SITE DISCOMFORT 88
122 CHEST PAIN 87
123 AGGRESSION 86
124 ABDOMINAL DISCOMFORT 85
125 ALOPECIA 85
126 DEHYDRATION 85
127 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 83
128 PRODUCT PREPARATION ERROR 83
129 ABNORMAL BEHAVIOUR 82
130 VIRAL INFECTION 82
131 VISION BLURRED 82
132 INTRACRANIAL PRESSURE INCREASED 80
133 HYPOAESTHESIA 78
134 OEDEMA PERIPHERAL 78
135 PRODUCT ADMINISTRATION ERROR 78
136 PRODUCT DISPENSING ERROR 78
137 BLOOD PRESSURE INCREASED 77
138 DISEASE RECURRENCE 75
139 IRRITABILITY 75
140 MUSCLE SPASMS 75
141 PALPITATIONS 75
142 JOINT SWELLING 74
143 HAEMORRHAGE 73
144 NERVOUSNESS 72
145 PITUITARY TUMOUR BENIGN 72
146 DIABETES MELLITUS 71
147 NEOPLASM RECURRENCE 71
148 ASTHMA 70
149 DRUG HYPERSENSITIVITY 70
150 INTENTIONAL PRODUCT USE ISSUE 70
151 LETHARGY 70
152 SNORING 70
153 CONFUSIONAL STATE 69
154 FLUID RETENTION 69
155 OROPHARYNGEAL PAIN 68
156 URINARY TRACT INFECTION 68
157 ANAEMIA 67
158 MEDICATION ERROR 67
159 NO ADVERSE EVENT 67
160 PARAESTHESIA 67
161 DRUG-INDUCED LIVER INJURY 66
162 NEOPLASM MALIGNANT 66
163 STRESS 66
164 PRESCRIBED OVERDOSE 65
165 THERAPEUTIC RESPONSE UNEXPECTED 65
166 MOOD ALTERED 64
167 MYOCARDIAL INFARCTION 63
168 SWELLING FACE 63
169 EPIPHYSIOLYSIS 62
170 OSTEOCHONDROSIS 62
171 PITUITARY TUMOUR 62
172 SURGERY 62
173 ACNE 61
174 ADENOIDAL HYPERTROPHY 61
175 ERYTHEMA 61
176 HEPATOTOXICITY 61
177 HEPATIC CIRRHOSIS 60
178 SLEEP DISORDER 60
179 SYRINGE ISSUE 60
180 EPISTAXIS 59
181 SINUSITIS 59
182 TREATMENT NONCOMPLIANCE 59
183 BLOOD GLUCOSE DECREASED 58
184 EAR INFECTION 58
185 INJECTION SITE PRURITUS 58
186 PAPILLOEDEMA 58
187 ADRENOCORTICAL INSUFFICIENCY ACUTE 56
188 HYPOTHYROIDISM 56
189 SWELLING 56
190 TACHYCARDIA 56
191 EYE PAIN 55
192 HEPATIC NECROSIS 55
193 MUSCULAR WEAKNESS 55
194 HEPATIC ENCEPHALOPATHY 54
195 ACUTE KIDNEY INJURY 53
196 AUTISM SPECTRUM DISORDER 53
197 DISTURBANCE IN ATTENTION 53
198 HEART RATE INCREASED 52
199 HYPOTENSION 52
200 NEOPLASM PROGRESSION 52
201 RHINORRHOEA 52
202 HYPOTHALAMO-PITUITARY DISORDER 51
203 IDIOPATHIC INTRACRANIAL HYPERTENSION 51
204 INCREASED APPETITE 51
205 INJECTION SITE DISCOLOURATION 51
206 OBESITY 51
207 OSTEONECROSIS 51
208 PRODUCT KNOWLEDGE DEFICIT 51
209 SEPSIS 51
210 MATERNAL EXPOSURE DURING PREGNANCY 50
211 NECK PAIN 50
212 THERAPY CHANGE 50
213 TYPE 2 DIABETES MELLITUS 50
214 BONE PAIN 49
215 BURNING SENSATION 49
216 COGNITIVE DISORDER 49
217 EYE SWELLING 49
218 HYPONATRAEMIA 49
219 INTENTIONAL DOSE OMISSION 49
220 MENTAL DISORDER 49
221 TONSILLAR HYPERTROPHY 49
222 ABORTION SPONTANEOUS 48
223 AGITATION 48
224 DEPRESSED MOOD 48
225 DISCOMFORT 48
226 GASTROENTERITIS 48
227 INJECTION SITE RASH 48
228 LOWER RESPIRATORY TRACT INFECTION 48
229 MENINGIOMA 48
230 PRODUCT DOSE OMISSION IN ERROR 48
231 RENAL FAILURE 48
232 DIABETES INSIPIDUS 47
233 EATING DISORDER 47
234 FEELING HOT 47
235 TYPE 1 DIABETES MELLITUS 47
236 GENERAL PHYSICAL HEALTH DETERIORATION 46
237 PRODUCT SUBSTITUTION ISSUE 46
238 RENAL DISORDER 46
239 ABDOMINAL DISTENSION 45
240 BLOOD ALKALINE PHOSPHATASE INCREASED 45
241 CARDIAC DISORDER 45
242 ILL-DEFINED DISORDER 45
243 INJURY ASSOCIATED WITH DEVICE 45
244 SUICIDAL IDEATION 45
245 ANGER 44
246 DRUG INTOLERANCE 44
247 HYPERGLYCAEMIA 44
248 MOOD SWINGS 44
249 DRY SKIN 43
250 NEOPLASM 43
251 PRODUCT PACKAGING QUANTITY ISSUE 43
252 PROSTATE CANCER 43
253 GLYCOSYLATED HAEMOGLOBIN INCREASED 42
254 HORMONE LEVEL ABNORMAL 42
255 HYPERSOMNIA 42
256 HYPOPITUITARISM 42
257 DEVICE FAILURE 41
258 EXPIRED PRODUCT ADMINISTERED 41
259 INCORRECT DOSAGE ADMINISTERED 41
260 PRODUCT LEAKAGE 41
261 UPPER LIMB FRACTURE 41
262 APNOEA 40
263 GASTROINTESTINAL DISORDER 40
264 HEAD INJURY 40
265 MUSCULOSKELETAL STIFFNESS 40
266 PALLOR 40
267 ADRENAL INSUFFICIENCY 39
268 BLINDNESS 39
269 CONVULSION 39
270 GROWTH FAILURE 39
271 OXYGEN SATURATION DECREASED 39
272 TRANSIENT ISCHAEMIC ATTACK 39
273 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38
274 LOWER LIMB FRACTURE 38
275 OEDEMA 38
276 AMNESIA 37
277 INCORRECT DRUG ADMINISTRATION RATE 37
278 INFLUENZA LIKE ILLNESS 37
279 BLOOD TEST ABNORMAL 36
280 EPIPHYSES PREMATURE FUSION 36
281 GLUCOSE TOLERANCE IMPAIRED 36
282 HYDROCEPHALUS 36
283 OBSTRUCTIVE SLEEP APNOEA SYNDROME 36
284 POOR QUALITY PRODUCT ADMINISTERED 36
285 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 36
286 PRODUCT PREPARATION ISSUE 36
287 TONSILLAR DISORDER 36
288 PRODUCT SUPPLY ISSUE 35
289 CHEST DISCOMFORT 34
290 DISEASE PROGRESSION 34
291 INFLAMMATION 34
292 CHILLS 33
293 DEVICE DISPENSING ERROR 33
294 FEMUR FRACTURE 33
295 GROWTH HORMONE DEFICIENCY 33
296 RHABDOMYOLYSIS 33
297 SKIN DISCOLOURATION 33
298 THYROID DISORDER 33
299 ACCIDENTAL OVERDOSE 32
300 BRAIN INJURY 32
301 BRONCHITIS 32
302 FLUSHING 32
303 HOT FLUSH 32
304 HYPERPHAGIA 32
305 LABORATORY TEST ABNORMAL 32
306 LYMPHADENOPATHY 32
307 THROMBOSIS 32
308 UNEVALUABLE EVENT 32
309 VERTIGO 32
310 BLOOD CHOLESTEROL INCREASED 31
311 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 31
312 GASTROENTERITIS VIRAL 31
313 POLLAKIURIA 31
314 PRODUCT CONTAINER ISSUE 31
315 VITAMIN D DEFICIENCY 31
316 APPENDICITIS 30
317 BALANCE DISORDER 30
318 CEREBRAL HAEMORRHAGE 30
319 INSULIN-LIKE GROWTH FACTOR DECREASED 30
320 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30
321 STEVENS-JOHNSON SYNDROME 30
322 ALANINE AMINOTRANSFERASE INCREASED 29
323 EMOTIONAL DISORDER 29
324 NASAL CONGESTION 29
325 PRODUCT DISTRIBUTION ISSUE 29
326 SKIN DISORDER 29
327 THIRST 29
328 ARTHRITIS 28
329 CHRONIC KIDNEY DISEASE 28
330 PRODUCT PHYSICAL ISSUE 28
331 RENAL IMPAIRMENT 28
332 ROAD TRAFFIC ACCIDENT 28
333 SCREAMING 28
334 TINNITUS 28
335 ADVERSE EVENT 27
336 BREAST CANCER 27
337 CARDIAC ARREST 27
338 CELLULITIS 27
339 GASTROOESOPHAGEAL REFLUX DISEASE 27
340 HAIR GROWTH ABNORMAL 27
341 HYPERTHYROIDISM 27
342 NEPHROLITHIASIS 27
343 OSTEOPOROSIS 27
344 PULMONARY HYPERTENSION 27
345 SPEECH DISORDER 27
346 UPPER RESPIRATORY TRACT INFECTION 27
347 ADVERSE DRUG REACTION 26
348 BLOOD CREATININE INCREASED 26
349 CARPAL TUNNEL SYNDROME 26
350 GAIT INABILITY 26
351 HALLUCINATION 26
352 HYPOACUSIS 26
353 INJECTION SITE URTICARIA 26
354 INSULIN RESISTANCE 26
355 MOBILITY DECREASED 26
356 PRODUCT PRESCRIBING ISSUE 26
357 PSYCHOMOTOR HYPERACTIVITY 26
358 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26
359 THROMBOCYTOPENIA 26
360 TIBIA FRACTURE 26
361 ACROMEGALY 25
362 ATRIAL FIBRILLATION 25
363 BLOOD SODIUM DECREASED 25
364 BONE DISORDER 25
365 DEPRESSED LEVEL OF CONSCIOUSNESS 25
366 DYSPEPSIA 25
367 DYSPHAGIA 25
368 FRACTURE 25
369 GASTROINTESTINAL INFECTION 25
370 HYPERNATRAEMIA 25
371 KNEE DEFORMITY 25
372 NEUTROPENIA 25
373 RESPIRATORY TRACT INFECTION 25
374 APPLICATION SITE PAIN 24
375 HAEMOGLOBIN DECREASED 24
376 HYPERTROPHIC CARDIOMYOPATHY 24
377 LACK OF INJECTION SITE ROTATION 24
378 OTITIS MEDIA 24
379 PANCREATITIS 24
380 PRODUCT COMPLAINT 24
381 STRABISMUS 24
382 ANGIOEDEMA 23
383 ANKLE FRACTURE 23
384 CATARACT 23
385 DRUG EFFECT LESS THAN EXPECTED 23
386 ENURESIS 23
387 EXTRA DOSE ADMINISTERED 23
388 HAEMATOCHEZIA 23
389 INJURY 23
390 BLOOD PRESSURE DECREASED 22
391 DEVICE DEPLOYMENT ISSUE 22
392 DIABETIC KETOACIDOSIS 22
393 EYE DISORDER 22
394 FLATULENCE 22
395 HYPOPHAGIA 22
396 NERVOUS SYSTEM DISORDER 22
397 PULMONARY EMBOLISM 22
398 RESPIRATORY FAILURE 22
399 SKIN LESION 22
400 STAPHYLOCOCCAL INFECTION 22
401 SUBARACHNOID HAEMORRHAGE 22
402 THROAT TIGHTNESS 22
403 UNRESPONSIVE TO STIMULI 22
404 AFFECTIVE DISORDER 21
405 BLOOD GROWTH HORMONE DECREASED 21
406 BRAIN OEDEMA 21
407 CARDIAC FAILURE 21
408 COMA 21
409 DEVICE INFORMATION OUTPUT ISSUE 21
410 DIABETES MELLITUS INADEQUATE CONTROL 21
411 DYSPHONIA 21
412 ECZEMA 21
413 FOOT FRACTURE 21
414 GLOMERULAR FILTRATION RATE DECREASED 21
415 GROWING PAINS 21
416 HYPERCALCAEMIA 21
417 INADVERTENT INJECTION AIR BUBBLE 21
418 JOINT STIFFNESS 21
419 MALIGNANT MELANOMA 21
420 MUSCULOSKELETAL PAIN 21
421 PITUITARY TUMOUR RECURRENT 21
422 POLYCYTHAEMIA 21
423 PRODUCT ODOUR ABNORMAL 21
424 PRODUCT TEMPERATURE EXCURSION ISSUE 21
425 SKIN EXFOLIATION 21
426 SKIN HAEMORRHAGE 21
427 THERAPEUTIC PRODUCT EFFECT DECREASED 21
428 CROHN^S DISEASE 20
429 DEAFNESS 20
430 DEMENTIA 20
431 HUMERUS FRACTURE 20
432 JOINT INJURY 20
433 LEUKAEMIA 20
434 LIMB DEFORMITY 20
435 PRODUCT COMMUNICATION ISSUE 20
436 PRODUCT SUBSTITUTION 20
437 SCRATCH 20
438 STOMATITIS 20
439 VIITH NERVE PARALYSIS 20
440 VITAMIN D DECREASED 20
441 ARNOLD-CHIARI MALFORMATION 19
442 BLOOD PARATHYROID HORMONE INCREASED 19
443 BRAIN NEOPLASM MALIGNANT 19
444 CEREBRAL DISORDER 19
445 CORONARY ARTERY DISEASE 19
446 ELECTROLYTE IMBALANCE 19
447 GLIONEURONAL TUMOUR 19
448 GROWTH DISORDER 19
449 HEPATOMEGALY 19
450 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19
451 INSURANCE ISSUE 19
452 INTENTIONAL SELF-INJURY 19
453 MASS 19
454 MELANOCYTIC NAEVUS 19
455 PANIC ATTACK 19
456 PHOTOPHOBIA 19
457 PLEURAL EFFUSION 19
458 POOR QUALITY SLEEP 19
459 PRESYNCOPE 19
460 SPINAL DISORDER 19
461 TENDON RUPTURE 19
462 THERAPEUTIC RESPONSE DECREASED 19
463 TONSILLITIS 19
464 WITHDRAWAL SYNDROME 19
465 WRIST FRACTURE 19
466 ADENOIDECTOMY 18
467 BASAL CELL CARCINOMA 18
468 BREAST PAIN 18
469 CARDIAC OPERATION 18
470 CONCUSSION 18
471 FOETAL EXPOSURE DURING PREGNANCY 18
472 HIP SURGERY 18
473 INJECTION SITE HAEMATOMA 18
474 INJECTION SITE VESICLES 18
475 LIGAMENT SPRAIN 18
476 METABOLIC ACIDOSIS 18
477 NEUROPATHY PERIPHERAL 18
478 PLATELET COUNT DECREASED 18
479 PRODUCT STORAGE ISSUE 18
480 PROTEIN-LOSING GASTROENTEROPATHY 18
481 RESPIRATORY DISORDER 18
482 RESPIRATORY DISTRESS 18
483 SUDDEN DEATH 18
484 ACCIDENT 17
485 ASTROCYTOMA 17
486 BLISTER 17
487 BLOOD POTASSIUM DECREASED 17
488 BLOOD TESTOSTERONE INCREASED 17
489 BLOOD THYROID STIMULATING HORMONE DECREASED 17
490 BLOOD TRIGLYCERIDES INCREASED 17
491 CARDIOMYOPATHY 17
492 COLITIS ULCERATIVE 17
493 CONJUNCTIVITIS 17
494 DRUG LEVEL INCREASED 17
495 ELECTRIC SHOCK SENSATION 17
496 ENERGY INCREASED 17
497 GERM CELL CANCER 17
498 HAEMATOMA 17
499 INCORRECT PRODUCT ADMINISTRATION DURATION 17
500 JOINT DISLOCATION 17
501 NEPHROTIC SYNDROME 17
502 PRODUCT ADMINISTRATION INTERRUPTED 17
503 PRODUCT CONTAMINATION 17
504 PROTEINURIA 17
505 RASH PRURITIC 17
506 RED BLOOD CELL COUNT DECREASED 17
507 THYROID CANCER 17
508 UNDERWEIGHT 17
509 WEIGHT FLUCTUATION 17
510 ANAPHYLACTIC SHOCK 16
511 ASPARTATE AMINOTRANSFERASE INCREASED 16
512 BLOOD INSULIN INCREASED 16
513 CARDIAC FAILURE CONGESTIVE 16
514 CIRCULATORY COLLAPSE 16
515 DRY MOUTH 16
516 EMOTIONAL DISTRESS 16
517 FAILURE TO THRIVE 16
518 HYPOGLYCAEMIC SEIZURE 16
519 INJECTION SITE ATROPHY 16
520 ISCHAEMIC STROKE 16
521 JUVENILE IDIOPATHIC ARTHRITIS 16
522 LIPODYSTROPHY ACQUIRED 16
523 LUNG DISORDER 16
524 LYMPHOMA 16
525 MEDULLOBLASTOMA 16
526 MEDULLOBLASTOMA RECURRENT 16
527 NIGHTMARE 16
528 PHAEOCHROMOCYTOMA 16
529 PRECOCIOUS PUBERTY 16
530 PRODUCT RECONSTITUTION QUALITY ISSUE 16
531 RASH GENERALISED 16
532 SKIN ODOUR ABNORMAL 16
533 TIC 16
534 TRANSAMINASES INCREASED 16
535 URINARY INCONTINENCE 16
536 WEIGHT GAIN POOR 16
537 AGEUSIA 15
538 ANGINA PECTORIS 15
539 ARRHYTHMIA 15
540 ARTHROPATHY 15
541 BLOOD BILIRUBIN INCREASED 15
542 BLOOD IRON DECREASED 15
543 BLOOD PROLACTIN INCREASED 15
544 BLOOD UREA INCREASED 15
545 CREUTZFELDT-JAKOB DISEASE 15
546 DEVICE OPERATIONAL ISSUE 15
547 DRUG DELIVERY SYSTEM ISSUE 15
548 ENDOCRINE DISORDER 15
549 EYE IRRITATION 15
550 FOOT DEFORMITY 15
551 HEPATIC STEATOSIS 15
552 HIP FRACTURE 15
553 HUNGER 15
554 INITIAL INSOMNIA 15
555 LIP SWELLING 15
556 LIVER DISORDER 15
557 OBSTRUCTIVE AIRWAYS DISORDER 15
558 OCULAR HYPERAEMIA 15
559 OESOPHAGEAL DISORDER 15
560 OSTEOARTHRITIS 15
561 OSTEOMYELITIS 15
562 PETIT MAL EPILEPSY 15
563 PNEUMONIA ASPIRATION 15
564 PRODUCT LABEL CONFUSION 15
565 PSORIASIS 15
566 RECURRENT CANCER 15
567 SNEEZING 15
568 WHEEZING 15
569 WHITE BLOOD CELL COUNT DECREASED 15
570 WOUND COMPLICATION 15
571 ANAPHYLACTIC REACTION 14
572 AORTIC VALVE DISEASE 14
573 ASTHMATIC CRISIS 14
574 ATRIOVENTRICULAR BLOCK COMPLETE 14
575 BLOOD DISORDER 14
576 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 14
577 BLOOD THYROID STIMULATING HORMONE INCREASED 14
578 CARDIOVASCULAR DISORDER 14
579 CHOLELITHIASIS 14
580 COLON CANCER 14
581 DENGUE FEVER 14
582 DERMATITIS ATOPIC 14
583 DISORIENTATION 14
584 DRUG ADMINISTRATION ERROR 14
585 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14
586 DYSKINESIA 14
587 DYSURIA 14
588 ERECTILE DYSFUNCTION 14
589 FAECES DISCOLOURED 14
590 FEELING COLD 14
591 FOCAL NODULAR HYPERPLASIA 14
592 GASTROINTESTINAL HAEMORRHAGE 14
593 GYNAECOMASTIA 14
594 HEAD DISCOMFORT 14
595 HIP ARTHROPLASTY 14
596 HYPONATRAEMIC SEIZURE 14
597 HYPOXIA 14
598 INJECTION SITE INJURY 14
599 INTESTINAL OBSTRUCTION 14
600 IRRITABLE BOWEL SYNDROME 14
601 LACRIMATION INCREASED 14
602 METABOLIC DISORDER 14
603 MUSCLE ATROPHY 14
604 MUSCULOSKELETAL DISCOMFORT 14
605 OVARIAN CYST 14
606 RASH MACULAR 14
607 RHEUMATOID ARTHRITIS 14
608 TONGUE DISCOLOURATION 14
609 TONSILLECTOMY 14
610 VENTRICULAR HYPERTROPHY 14
611 BENIGN INTRACRANIAL HYPERTENSION 13
612 BLOOD CREATINE PHOSPHOKINASE INCREASED 13
613 BLOOD GLUCOSE ABNORMAL 13
614 BLOOD URINE PRESENT 13
615 BODY TEMPERATURE INCREASED 13
616 BRAIN FOG 13
617 CARDIO-RESPIRATORY ARREST 13
618 CEREBRAL SALT-WASTING SYNDROME 13
619 COELIAC DISEASE 13
620 FEEDING DISORDER 13
621 FOOD ALLERGY 13
622 GENERALISED TONIC-CLONIC SEIZURE 13
623 GLIOBLASTOMA 13
624 HAEMATOCRIT INCREASED 13
625 HEPATIC ENZYME INCREASED 13
626 HEPATOBLASTOMA 13
627 HYPOKALAEMIA 13
628 INTERVERTEBRAL DISC PROTRUSION 13
629 KIDNEY INFECTION 13
630 LEFT VENTRICULAR HYPERTROPHY 13
631 LIMB INJURY 13
632 MENTAL IMPAIRMENT 13
633 MUSCLE TIGHTNESS 13
634 NIGHT SWEATS 13
635 OSTEOSARCOMA 13
636 PARTIAL SEIZURES 13
637 PERIORBITAL SWELLING 13
638 PREMATURE BABY 13
639 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 13
640 PRODUCT DISPENSING ISSUE 13
641 PRODUCT PACKAGING ISSUE 13
642 PRODUCTIVE COUGH 13
643 SEASONAL ALLERGY 13
644 TOOTH DISORDER 13
645 ACUTE MYOCARDIAL INFARCTION 12
646 ATTENTION DEFICIT HYPERACTIVITY DISORDER 12
647 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 12
648 BLOOD GROWTH HORMONE INCREASED 12
649 BONE DENSITY DECREASED 12
650 DEVICE RELATED INFECTION 12
651 DIPLOPIA 12
652 DRUG PRESCRIBING ERROR 12
653 DYSSTASIA 12
654 EAR PAIN 12
655 EYE HAEMORRHAGE 12
656 FACE OEDEMA 12
657 FEAR 12
658 FLUID INTAKE REDUCED 12
659 GASTRIC HAEMORRHAGE 12
660 GRANULOMA 12
661 HEMIPARESIS 12
662 HEPATITIS 12
663 HIGH DENSITY LIPOPROTEIN DECREASED 12
664 HYPERLIPIDAEMIA 12
665 HYPOPHYSITIS 12
666 IMMUNE SYSTEM DISORDER 12
667 IN VITRO FERTILISATION 12
668 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12
669 INJECTION SITE SCAR 12
670 MENOPAUSE 12
671 MIDDLE INSOMNIA 12
672 MOVEMENT DISORDER 12
673 MUSCLE TWITCHING 12
674 OCULAR DISCOMFORT 12
675 OSTEOCHONDROMA 12
676 PHARYNGITIS STREPTOCOCCAL 12
677 POST PROCEDURAL COMPLICATION 12
678 PRE-EXISTING CONDITION IMPROVED 12
679 PRIMARY HYPOTHYROIDISM 12
680 PRODUCT CONTAMINATION PHYSICAL 12
681 PRODUCT DELIVERY MECHANISM ISSUE 12
682 PRODUCT DEPOSIT 12
683 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12
684 RESTLESSNESS 12
685 RETCHING 12
686 SECONDARY HYPOGONADISM 12
687 SHOCK 12
688 SPINAL DEFORMITY 12
689 SPINAL OPERATION 12
690 SYRINGOMYELIA 12
691 THERAPY NON-RESPONDER 12
692 URINARY RETENTION 12
693 VISUAL ACUITY REDUCED 12
694 ACUTE MYELOID LEUKAEMIA 11
695 ADRENAL DISORDER 11
696 APNOEIC ATTACK 11
697 APPENDIX DISORDER 11
698 ASTROCYTOMA, LOW GRADE 11
699 BEHAVIOUR DISORDER 11
700 BLOOD PRESSURE DIASTOLIC DECREASED 11
701 BONE DEVELOPMENT ABNORMAL 11
702 BREAST DISCOMFORT 11
703 BREAST SWELLING 11
704 CEREBRAL INFARCTION 11
705 COAGULOPATHY 11
706 DEMENTIA ALZHEIMER^S TYPE 11
707 DYSGEUSIA 11
708 EXCESSIVE EYE BLINKING 11
709 GASTRITIS 11
710 GROWTH ACCELERATED 11
711 HAEMATURIA 11
712 HEPATIC NEOPLASM 11
713 HERNIA 11
714 IMMUNODEFICIENCY 11
715 IMPULSIVE BEHAVIOUR 11
716 INABILITY TO AFFORD MEDICATION 11
717 INCORRECT PRODUCT STORAGE 11
718 INFERTILITY 11
719 INGUINAL HERNIA 11
720 INJECTION SITE INDURATION 11
721 INTENTIONAL OVERDOSE 11
722 INTRAOCULAR PRESSURE INCREASED 11
723 LUNG NEOPLASM MALIGNANT 11
724 MALOCCLUSION 11
725 MUSCLE DISORDER 11
726 MUSCULOSKELETAL DISORDER 11
727 NEURALGIA 11
728 NON-HODGKIN^S LYMPHOMA 11
729 PANCREATITIS ACUTE 11
730 PAPILLARY THYROID CANCER 11
731 PERFORMANCE ENHANCING PRODUCT USE 11
732 PERIPHERAL COLDNESS 11
733 PNEUMOTHORAX 11
734 PRODUCT LABEL ISSUE 11
735 PSYCHOTIC DISORDER 11
736 RECTAL HAEMORRHAGE 11
737 SKIN STRIAE 11
738 SPLENOMEGALY 11
739 STRESS FRACTURE 11
740 SUICIDE ATTEMPT 11
741 TEETHING 11
742 TENSION 11
743 URINE OUTPUT INCREASED 11
744 WRONG PRODUCT ADMINISTERED 11
745 ADDISON^S DISEASE 10
746 ADENOIDAL DISORDER 10
747 ADMINISTRATION SITE PAIN 10
748 BACK DISORDER 10
749 BRADYCARDIA 10
750 BRAIN OPERATION 10
751 BREAST ENLARGEMENT 10
752 BRONCHOSPASM 10
753 C-REACTIVE PROTEIN INCREASED 10
754 CANDIDA INFECTION 10
755 CONCOMITANT DISEASE AGGRAVATED 10
756 CONTRAINDICATED PRODUCT ADMINISTERED 10
757 CRYPTORCHISM 10
758 CYST 10
759 DELAYED PUBERTY 10
760 DEVELOPMENTAL HIP DYSPLASIA 10
761 DEVICE CONNECTION ISSUE 10
762 DISABILITY 10
763 DRUG DISPENSING ERROR 10
764 DYSARTHRIA 10
765 EDUCATIONAL PROBLEM 10
766 FRUSTRATION TOLERANCE DECREASED 10
767 GLIOMA 10
768 GLUCOCORTICOID DEFICIENCY 10
769 GOITRE 10
770 HAND FRACTURE 10
771 HERPES ZOSTER 10
772 HYPOTHERMIA 10
773 IMPAIRED HEALING 10
774 INTRA-ABDOMINAL HAEMORRHAGE 10
775 IRON DEFICIENCY 10
776 KNEE OPERATION 10
777 LIMB ASYMMETRY 10
778 LYMPHOEDEMA 10
779 MALNUTRITION 10
780 MULTIPLE SCLEROSIS RELAPSE 10
781 MULTIPLE-DRUG RESISTANCE 10
782 NOCTURIA 10
783 OBLITERATIVE BRONCHIOLITIS 10
784 OSTEOPENIA 10
785 OVERWEIGHT 10
786 PERITONITIS 10
787 PERTHES DISEASE 10
788 PHARYNGEAL SWELLING 10
789 PIGMENTATION DISORDER 10
790 PULMONARY OEDEMA 10
791 RENAL TRANSPLANT 10
792 RESPIRATORY ARREST 10
793 SARS-COV-2 TEST POSITIVE 10
794 SKIN IRRITATION 10
795 SULPHAEMOGLOBINAEMIA 10
796 SYSTEMIC LUPUS ERYTHEMATOSUS 10
797 TENOSYNOVITIS STENOSANS 10
798 ULNA FRACTURE 10
799 VEIN DISORDER 10
800 WRONG DOSE 10
801 ABNORMAL DREAMS 9
802 ADMINISTRATION SITE BRUISE 9
803 AORTIC ANEURYSM 9
804 APPLICATION SITE ERYTHEMA 9
805 ARTERIOSCLEROSIS CORONARY ARTERY 9
806 ASPHYXIA 9
807 AUTOIMMUNE DISORDER 9
808 AVULSION FRACTURE 9
809 BREAST MASS 9
810 CARDIOMEGALY 9
811 CEREBRAL AMYLOID ANGIOPATHY 9
812 CEREBRAL ATROPHY 9
813 CEREBRAL CYST 9
814 CHOLESTEATOMA 9
815 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9
816 COLITIS 9
817 CORONAVIRUS INFECTION 9
818 DEVELOPMENTAL DELAY 9
819 DEVICE LOOSENING 9
820 DIVERTICULITIS 9
821 DIZZINESS POSTURAL 9
822 DRUG WITHDRAWAL SYNDROME 9
823 EXOSTOSIS 9
824 FEBRILE CONVULSION 9
825 FILARIASIS LYMPHATIC 9
826 FUNGAL INFECTION 9
827 GENERALISED OEDEMA 9
828 GLAUCOMA 9
829 GROIN PAIN 9
830 HEART RATE DECREASED 9
831 HEPATIC FAILURE 9
832 INFANTILE HAEMANGIOMA 9
833 INTENTIONAL DEVICE MISUSE 9
834 INTERCEPTED PRODUCT PRESCRIBING ERROR 9
835 LARYNGEAL OEDEMA 9
836 LEUKOPENIA 9
837 LIMB DISCOMFORT 9
838 LOCALISED INFECTION 9
839 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9
840 PANCYTOPENIA 9
841 PARALYSIS 9
842 PERSONALITY CHANGE 9
843 PITUITARY HAEMORRHAGE 9
844 PRODUCT COLOUR ISSUE 9
845 PRODUCT CONTAMINATION WITH BODY FLUID 9
846 RASH ERYTHEMATOUS 9
847 RHINITIS 9
848 RHINOVIRUS INFECTION 9
849 SEPTIC SHOCK 9
850 SOLAR LENTIGO 9
851 SOMNAMBULISM 9
852 SPINAL STENOSIS 9
853 STUBBORNNESS 9
854 TALIPES 9
855 TENDON CALCIFICATION 9
856 THYROID NEOPLASM 9
857 TOBACCO ABUSE 9
858 TOXIC CARDIOMYOPATHY 9
859 TREATMENT FAILURE 9
860 VITH NERVE PARALYSIS 9
861 ACUTE LYMPHOCYTIC LEUKAEMIA 8
862 ANDROPAUSE 8
863 ANHEDONIA 8
864 ASCITES 8
865 BACTERAEMIA 8
866 BLOOD SODIUM INCREASED 8
867 CHOKING 8
868 CHOLECYSTECTOMY 8
869 CRANIOCEREBRAL INJURY 8
870 CYSTITIS 8
871 DEREALISATION 8
872 DRY EYE 8
873 EAR DISORDER 8
874 EMBOLISM 8
875 ENCEPHALOPATHY 8
876 EXPOSURE DURING PREGNANCY 8
877 GALLBLADDER DISORDER 8
878 HAEMATEMESIS 8
879 HAEMOGLOBIN INCREASED 8
880 HAIR TEXTURE ABNORMAL 8
881 HALLUCINATION, AUDITORY 8
882 HEAVY MENSTRUAL BLEEDING 8
883 HYPERTENSIVE CRISIS 8
884 INFECTIOUS MONONUCLEOSIS 8
885 INJECTION SITE INFLAMMATION 8
886 INJECTION SITE IRRITATION 8
887 INJECTION SITE PARAESTHESIA 8
888 INJECTION SITE WARMTH 8
889 KIDNEY ENLARGEMENT 8
890 LARYNGITIS 8
891 LEARNING DISORDER 8
892 LIBIDO DECREASED 8
893 LUNG INFECTION 8
894 MENSTRUATION IRREGULAR 8
895 MENTAL STATUS CHANGES 8
896 MYCOBACTERIUM AVIUM COMPLEX INFECTION 8
897 MYCOBACTERIUM CHELONAE INFECTION 8
898 MYELODYSPLASTIC SYNDROME 8
899 MYOSITIS 8
900 NAIL BED DISORDER 8
901 NERVE INJURY 8
902 NEUTROPHILIC PANNICULITIS 8
903 NO THERAPEUTIC RESPONSE 8
904 OBSESSIVE-COMPULSIVE DISORDER 8
905 ONYCHOCLASIS 8
906 OPTIC NEURITIS 8
907 OTITIS MEDIA ACUTE 8
908 PAIN OF SKIN 8
909 PARKINSON^S DISEASE 8
910 PEPTIC ULCER 8
911 PERIORBITAL OEDEMA 8
912 PHOTOSENSITIVITY REACTION 8
913 PRIMARY HYPOGONADISM 8
914 PRODUCT APPEARANCE CONFUSION 8
915 PRURITUS GENERALISED 8
916 PYELONEPHRITIS 8
917 REFUSAL OF TREATMENT BY PATIENT 8
918 SELF-MEDICATION 8
919 SENSORY DISTURBANCE 8
920 SPINAL CORD COMPRESSION 8
921 STRIDOR 8
922 TESTIS CANCER 8
923 THROAT IRRITATION 8
924 TOXICITY TO VARIOUS AGENTS 8
925 TREATMENT DELAYED 8
926 TUBULOINTERSTITIAL NEPHRITIS 8
927 TUMOUR HAEMORRHAGE 8
928 TUMOUR NECROSIS 8
929 VASOGENIC CEREBRAL OEDEMA 8
930 VENOUS HAEMORRHAGE 8
931 ABASIA 7
932 ABDOMINAL PAIN LOWER 7
933 AFFECT LABILITY 7
934 AMBLYOPIA 7
935 ANAL INFECTION 7
936 APPENDICECTOMY 7
937 APPLICATION SITE HAEMORRHAGE 7
938 ATYPICAL PNEUMONIA 7
939 BASEDOW^S DISEASE 7
940 BEDRIDDEN 7
941 BLADDER CANCER 7
942 BLINDNESS UNILATERAL 7
943 BLOOD TESTOSTERONE DECREASED 7
944 BODY HEIGHT DECREASED 7
945 BRAIN MIDLINE SHIFT 7
946 BRUXISM 7
947 CENTRAL NERVOUS SYSTEM LESION 7
948 COLD SWEAT 7
949 CONGENITAL CYSTIC KIDNEY DISEASE 7
950 CORONARY ARTERY BYPASS 7
951 CUSHING^S SYNDROME 7
952 DERMATILLOMANIA 7
953 DERMATITIS CONTACT 7
954 DEVICE DISLOCATION 7
955 DEVICE USE CONFUSION 7
956 DIALYSIS 7
957 DRUG DEPENDENCE 7
958 ECONOMIC PROBLEM 7
959 END STAGE RENAL DISEASE 7
960 ENDOCRINE OPHTHALMOPATHY 7
961 FIBROMYALGIA 7
962 GASTROINTESTINAL CARCINOMA 7
963 GENITAL BURNING SENSATION 7
964 GINGIVAL BLEEDING 7
965 GLIOBLASTOMA MULTIFORME 7
966 HAEMORRHAGE INTRACRANIAL 7
967 HELICOBACTER INFECTION 7
968 HEMIANOPIA 7
969 HEPATIC FUNCTION ABNORMAL 7
970 HYDRONEPHROSIS 7
971 HYPERTRICHOSIS 7
972 HYPERURICAEMIA 7
973 HYPERVOLAEMIA 7
974 HYPOTONIA 7
975 IMPAIRED GASTRIC EMPTYING 7
976 IMPAIRED QUALITY OF LIFE 7
977 INJECTION SITE HYPERSENSITIVITY 7
978 LIGAMENT RUPTURE 7
979 LIPOMA 7
980 MANUFACTURING PRODUCT SHIPPING ISSUE 7
981 MELAENA 7
982 MENINGITIS ASEPTIC 7
983 MICTURITION URGENCY 7
984 MOUTH BREATHING 7
985 MUSCULOSKELETAL CHEST PAIN 7
986 NERVE COMPRESSION 7
987 ORTHOSTATIC HYPOTENSION 7
988 PAIN IN JAW 7
989 PETECHIAE 7
990 PHARYNGITIS 7
991 PNEUMONIA BACTERIAL 7
992 POISONING 7
993 PROGNATHISM 7
994 PULMONARY VALVE STENOSIS 7
995 RASH PAPULAR 7
996 RENAL PAIN 7
997 SARCOMA 7
998 SCAR 7
999 SCIATICA 7